Cite
Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer.
MLA
Xu, Wei, et al. “Survival and Safety Analysis of COVID‐19 Vaccine in Chinese Patients with Non‐small Cell Lung Cancer.” Cancer Medicine, vol. 13, no. 8, Apr. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1002/cam4.7032.
APA
Xu, W., Zhao, J., Luan, F., Zhang, Z., Liu, L., Zhao, H., Feng, B., & Fu, G. (2024). Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer. Cancer Medicine, 13(8), 1–11. https://doi.org/10.1002/cam4.7032
Chicago
Xu, Wei, Jing Zhao, Fang Luan, Zhizhao Zhang, Lei Liu, Hui Zhao, Bin Feng, and Guobin Fu. 2024. “Survival and Safety Analysis of COVID‐19 Vaccine in Chinese Patients with Non‐small Cell Lung Cancer.” Cancer Medicine 13 (8): 1–11. doi:10.1002/cam4.7032.